Nanosonics Limited (ASX:NAN)

Market Cap	1.35B
Revenue (ttm)	183.97M
Net Income (ttm)	16.56M
Shares Out	303.60M
EPS (ttm)	0.05
PE Ratio	83.63
Forward PE	70.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	417,635
Average Volume	907,123
Open	4.420
Previous Close	4.440
Day's Range	4.410 - 4.510
52-Week Range	2.640 - 5.180
Beta	1.77
RSI	44.51
Earnings Date	May 21, 2025

About Nanosonics

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technolo...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 466
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NAN

Financial Performance

In 2024, Nanosonics's revenue was 170.01 million, an increase of 2.42% compared to the previous year's 165.99 million. Earnings were 12.97 million, a decrease of -34.76%.